Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
Phase IB/II Evaluation of RAD001 with Docetaxel and Bevacizumab in Patients with Metastatic Androgen-Independent Prostate Cancer.
Closed to Accrual with Ongoing Follow-up
Chemotherapy: Systemic, Immunotherapy
Defintions of terms and FAQ about clinical trials.
Mitchell Gross, M.D.
Other Trial Staff:
Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Carol Jones, R.N., Olga Castellanos, Coordinator, Ernesto Duverger, D.M., Elysse Faye Ballon, Coordinator
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.